Myomo (MYO) Debt Ratio (2017 - 2025)

Myomo (MYO) posted Debt Ratio of 0.36 for Q4 2025, up 310.29% on a QoQ basis from 0.09 in Q3 2025, and up 35.97% year-over-year from 0.27 in Q4 2024.

Myomo (MYO) Debt Ratio (2017 - 2025) Analysis & Trends

Myomo's Debt Ratio history runs 5 years deep, the most recent figure standing at 0.36 for Q4 2025.

Quarterly Debt Ratio rose 35.97% year-over-year to 0.36 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.36 (up 35.97% YoY) and the FY2025 annual result came in at 0.36, up 35.97% from the prior year.
Debt Ratio was 0.36 for Q4 2025 at Myomo, up from 0.09 in the prior quarter.
Across five years, Debt Ratio topped out at 0.36 in Q4 2025 and bottomed at 0.09 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.31
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	0.32
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	0.30
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	0.04
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	0.30
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	0.27
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	0.30
10	Myomo	39.24 Mn	20.27 Mn	-	0.36

Download Data